W. Gepts, Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus, Diabetes, vol.14, issue.10, pp.619-652, 1965.
DOI : 10.2337/diab.14.10.619

M. Donath, M. Boni-schnetzler, H. Ellingsgaard, and J. Ehses, Islet Inflammation Impairs the Pancreatic ??-Cell in Type 2 Diabetes, Physiology, vol.24, issue.6, pp.325-356, 2009.
DOI : 10.1152/physiol.00032.2009

M. Donath and S. Shoelson, Type 2 diabetes as an inflammatory disease, Nature Reviews Immunology, vol.52, issue.2, pp.98-107, 2011.
DOI : 10.1038/nri2925

A. Bendelac, P. Savage, and L. Teyton, The Biology of NKT Cells, Annual Review of Immunology, vol.25, issue.1, pp.297-336, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141711

L. Bourhis, L. Guerri, L. Dusseaux, M. Martin, E. Soudais et al., Mucosalassociated invariant T cells: unconventional development and function, Trends Immunol, vol.32, issue.5, 2011.

I. Magalhaes, K. Pingris, C. Poitou, S. Bessoles, N. Venteclef et al., Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients, Journal of Clinical Investigation, vol.125, issue.4, pp.1752-62, 2015.
DOI : 10.1172/JCI78941DS1

J. Gombert, A. Herbelin, E. Tancrede-bohin, M. Dy, C. Carnaud et al., Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse, European Journal of Immunology, vol.19, issue.12, pp.2989-98, 1996.
DOI : 10.1002/eji.1830261226

A. Baxter, S. Kinder, K. Hammond, R. Scollay, and D. Godfrey, Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice, Diabetes, vol.46, issue.4, pp.572-82, 1997.
DOI : 10.2337/diabetes.46.4.572

Y. Chen, S. Tsaih, and D. Serreze, Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type, Genes and Immunity, vol.178, issue.2, pp.164-74, 2012.
DOI : 10.1038/nmeth.1359

M. Jordan, J. Fletcher, D. Pellicci, and A. Baxter, Slamf1, the NKT Cell Control Gene Nkt1, The Journal of Immunology, vol.178, issue.3, pp.1618-1645, 2007.
DOI : 10.4049/jimmunol.178.3.1618

D. Baev, S. Caielli, F. Ronchi, M. Coccia, F. Facciotti et al., Impaired SLAM-SLAM Homotypic Interaction between Invariant NKT Cells and Dendritic Cells Affects Differentiation of IL-4/IL-10-Secreting NKT2 Cells in Nonobese Diabetic Mice, The Journal of Immunology, vol.181, issue.2, pp.869-77, 2008.
DOI : 10.4049/jimmunol.181.2.869

S. Tsaih, S. Khaja, A. Ciecko, E. Mackinney, and Y. Chen, Genetic control of murine invariant natural killer T cells maps to multiple type 1 diabetes regions, Genes and Immunity, vol.159, issue.6, pp.380-386, 2013.
DOI : 10.1359/jbmr.060510

J. Fletcher, M. Jordan, S. Snelgrove, R. Slattery, F. Dufour et al., Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp4, The Journal of Immunology, vol.181, issue.5, pp.3400-3412, 2008.
DOI : 10.4049/jimmunol.181.5.3400

S. Tsaih, M. Presa, S. Khaja, A. Ciecko, D. Serreze et al., A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells, Genes and Immunity, vol.159, issue.3, pp.221-251, 2015.
DOI : 10.1359/jbmr.060510

Y. Simoni, A. Gautron, L. Beaudoin, L. Bui, M. Michel et al., NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes, European Journal of Immunology, vol.208, issue.12
DOI : 10.1002/eji.201141751

URL : https://hal.archives-ouvertes.fr/hal-00655397

L. Ghazarian, Y. Simoni, I. Magalhaes, and A. Lehuen, Invariant NKT cell development: focus on NOD mice, Current Opinion in Immunology, vol.27, 2014.
DOI : 10.1016/j.coi.2014.02.004

B. Wang, Y. Geng, and C. Wang, Cd1-Restricted Nk T Cells Protect Nonobese Diabetic Mice from Developing Diabetes, The Journal of Experimental Medicine, vol.163, issue.3, pp.313-333, 2001.
DOI : 10.1084/jem.188.8.1529

F. Shi, M. Flodstrom, B. Balasa, S. Kim, K. Van-gunst et al., Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse, Proceedings of the National Academy of Sciences, vol.98, issue.12, pp.6777-82, 2001.
DOI : 10.1073/pnas.121169698

K. Hammond, L. Poulton, L. Palmisano, P. Silveira, D. Godfrey et al., (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10, The Journal of Experimental Medicine, vol.158, issue.7, pp.1047-56, 1998.
DOI : 10.1084/jem.186.1.109

A. Lehuen, O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud et al., Overexpression of Natural Killer T Cells Protects V??14-J??281 Transgenic Nonobese Diabetic Mice against Diabetes, The Journal of Experimental Medicine, vol.110, issue.10, pp.1831-1840, 1998.
DOI : 10.1126/science.274.5284.50

V. Laloux, L. Beaudoin, D. Jeske, C. Carnaud, and A. Lehuen, NK T Cell-Induced Protection Against Diabetes in V??14-J??281 Transgenic Nonobese Diabetic Mice Is Associated with a Th2 Shift Circumscribed Regionally to the Islets and Functionally to Islet Autoantigen, The Journal of Immunology, vol.166, issue.6, pp.3749-56, 2001.
DOI : 10.4049/jimmunol.166.6.3749

S. Hong, M. Wilson, I. Serizawa, L. Wu, N. Singh et al., The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice, Nature Medicine, vol.7, issue.9, pp.1052-1058, 2001.
DOI : 10.1038/nm0901-1052

S. Sharif, G. Arreaza, P. Zucker, Q. Mi, J. Sondhi et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes, Nature Medicine, vol.7, issue.9, pp.1057-62, 2001.
DOI : 10.1038/nm0901-1057

Y. Chen, C. Choisy-rossi, T. Holl, H. Chapman, G. Besra et al., Activated NKT Cells Inhibit Autoimmune Diabetes through Tolerogenic Recruitment of Dendritic Cells to Pancreatic Lymph Nodes, The Journal of Immunology, vol.174, issue.3, pp.1196-204, 2005.
DOI : 10.4049/jimmunol.174.3.1196

L. Beaudoin, D. J. Ghazarian, L. Simoni, Y. Boitard, C. Lehuen et al., Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes, European Journal of Immunology, vol.22, issue.5, pp.1454-66, 2014.
DOI : 10.1002/eji.201343910

L. Beaudoin, V. Laloux, J. Novak, B. Lucas, and A. Lehuen, NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic ?? Cells, Immunity, vol.17, issue.6, pp.725-761, 2002.
DOI : 10.1016/S1074-7613(02)00473-9

J. Novak, L. Beaudoin, T. Griseri, and A. Lehuen, Inhibition of T Cell Differentiation into Effectors by NKT Cells Requires Cell Contacts, The Journal of Immunology, vol.174, issue.4, pp.1954-61, 1954.
DOI : 10.4049/jimmunol.174.4.1954

J. Diana, V. Brezar, L. Beaudoin, M. Dalod, A. Mellor et al., Viral infection prevents diabetes by inducing regulatory T cells through NKT cell???plasmacytoid dendritic cell interplay, The Journal of Experimental Medicine, vol.958, issue.4, pp.729-774, 2011.
DOI : 10.1016/j.pt.2007.10.006

URL : https://hal.archives-ouvertes.fr/hal-00608142

L. Ghazarian, D. J. Beaudoin, L. Larsson, P. Puri, R. Van-rooijen et al., Protection Against Type 1 Diabetes Upon Coxsackievirus B4 Infection and iNKT-Cell Stimulation: Role of Suppressive Macrophages, Diabetes, vol.62, issue.11, pp.3785-96, 2013.
DOI : 10.2337/db12-0958

URL : https://hal.archives-ouvertes.fr/tel-01071267

A. Rabinovitch and W. Suarez-pinzon, Role of cytokines in the pathogenesis of autoimmune diabetes mellitus, Reviews in Endocrine and Metabolic Disorders, vol.4, issue.3, pp.291-300, 2003.
DOI : 10.1023/A:1025160614313

S. Wilson, S. Kent, K. Patton, T. Orban, R. Jackson et al., Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes, Nature, vol.391, issue.6663, pp.177-811034419, 1038.

A. Kukreja, G. Cost, J. Marker, C. Zhang, Z. Sun et al., Multiple immuno-regulatory defects in type-1 diabetes, Journal of Clinical Investigation, vol.109, issue.1, pp.131-171, 2002.
DOI : 10.1172/JCI0213605

J. Kis, P. Engelmann, K. Farkas, G. Richman, S. Eck et al., Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus, Journal of Leukocyte Biology, vol.81, issue.3, pp.654-62, 2007.
DOI : 10.1189/jlb.1106654

Y. Oikawa, A. Shimada, S. Yamada, Y. Motohashi, Y. Nakagawa et al., High Frequency of V??24+ V??11+ T-Cells Observed in Type 1 Diabetes, Diabetes Care, vol.25, issue.10, pp.1818-1841, 2002.
DOI : 10.2337/diacare.25.10.1818

P. Lee, A. Putnam, K. Benlagha, L. Teyton, P. Gottlieb et al., Testing the NKT cell hypothesis of human IDDM pathogenesis, Journal of Clinical Investigation, vol.110, issue.6, pp.793-800, 2002.
DOI : 10.1172/JCI0215832

Y. Tsutsumi, X. Jie, K. Ihara, A. Nomura, S. Kanemitsu et al., Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type??1 diabetes, Diabetic Medicine, vol.397, issue.10, pp.1145-50, 2006.
DOI : 10.1111/j.1464-5491.2006.01951.x

V. Oling, J. Marttila, M. Knip, O. Simell, and J. Ilonen, Circulating CD4+CD25high Regulatory T Cells and Natural Killer T Cells in Children with Newly Diagnosed Type 1 Diabetes or with Diabetes-Associated Autoantibodies, Annals of the New York Academy of Sciences, vol.141, issue.1, pp.363-72, 2007.
DOI : 10.1084/jem.20060772

A. Roman-gonzalez, M. Moreno, J. Alfaro, F. Uribe, G. Latorre-sierra et al., Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients, Human Immunology, vol.70, issue.4, pp.262-270, 2009.
DOI : 10.1016/j.humimm.2009.01.012

S. Li, C. Joseph, C. Becourt, J. Klibi, S. Luce et al., Potential Role of IL-17-Producing iNKT Cells in Type 1 Diabetes, PLoS ONE, vol.56, issue.4, 2014.
DOI : 10.1371/journal.pone.0096151.s004

M. Cornelis and F. Hu, Gene-Environment Interactions in the Development of Type 2 Diabetes: Recent Progress and Continuing Challenges, Annual Review of Nutrition, vol.32, issue.1, pp.245-59, 2012.
DOI : 10.1146/annurev-nutr-071811-150648

G. Hotamisligil, N. Shargill, and B. Spiegelman, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, vol.259, issue.5091, pp.87-91, 1993.
DOI : 10.1126/science.7678183

L. Lynch, M. Nowak, B. Varghese, J. Clark, A. Hogan et al., Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production, Immunity, vol.37, issue.3, pp.574-87, 2012.
DOI : 10.1016/j.immuni.2012.06.016

URL : http://doi.org/10.1016/j.immuni.2012.06.016

L. Wu, V. Parekh, C. Gabriel, D. Bracy, P. Marks-shulman et al., Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice, Proceedings of the National Academy of Sciences, vol.109, issue.19, pp.1143-52, 2012.
DOI : 10.1073/pnas.1200498109

D. Mathis, Immunological Goings-on in Visceral Adipose Tissue, Cell Metabolism, vol.17, issue.6, pp.851-860, 2013.
DOI : 10.1016/j.cmet.2013.05.008

L. Lynch, Adipose invariant natural killer T cells, Immunology, vol.10, issue.3, pp.337-383, 2014.
DOI : 10.1111/imm.12269

L. Lynch, X. Michelet, S. Zhang, P. Brennan, A. Moseman et al., Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue, Nature Immunology, vol.14, issue.1, pp.85-95, 2015.
DOI : 10.1038/ni.3047

L. Lynch, O. Shea, D. Winter, D. Geoghegan, J. Doherty et al., cells amass in human omentum and are depleted in patients with cancer and obesity, European Journal of Immunology, vol.67, issue.7, pp.1893-901, 2009.
DOI : 10.1002/eji.200939349

R. Reantragoon, A. Corbett, I. Sakala, N. Gherardin, J. Furness et al., Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells, The Journal of Experimental Medicine, vol.24, issue.11, pp.2305-2325, 2013.
DOI : 10.1007/978-1-60327-058-8_28

M. Shimamura, Y. Huang, H. Goji, S. Endo, R. Migishima et al., Regulation of immunological disorders by invariant Valpha19-Jalpha33 TCR-bearing cells, Immunobiology, vol.216, issue.3, 2011.

R. Harms, K. Lorenzo, K. Corley, M. Cabrera, and N. Sarvetnick, Altered CD161bright CD8+ Mucosal Associated Invariant T (MAIT)-Like Cell Dynamics and Increased Differentiation States among Juvenile Type 1 Diabetics, PLOS ONE, vol.44, issue.Suppl 1, 2015.
DOI : 10.1371/journal.pone.0117335.s002

URL : http://doi.org/10.1371/journal.pone.0117335

J. Novak, J. Dobrovolny, L. Novakova, and T. Kozak, The Decrease in Number and Change in Phenotype of Mucosal-Associated Invariant T cells in the Elderly and Differences in Men and Women of Reproductive Age, Scandinavian Journal of Immunology, vol.49, issue.4, pp.271-276, 2014.
DOI : 10.1111/sji.12193

J. Ribot, A. Pang, D. Neves, J. Peperzak, V. Roberts et al., CD27 is a thymic determinant of the balance between interferon-??- and interleukin 17???producing ???? T cell subsets, Nature Immunology, vol.170, issue.4, pp.427-463, 2009.
DOI : 10.1038/ni.1717

P. Muranski and N. Restifo, Essentials of Th17 cell commitment and plasticity, Blood, vol.121, issue.13, pp.2402-1410, 2013.
DOI : 10.1182/blood-2012-09-378653

E. Carolan, L. Tobin, B. Mangan, M. Corrigan, G. Gaoatswe et al., Altered Distribution and Increased IL-17 Production by Mucosal-Associated Invariant T Cells in Adult and Childhood Obesity, The Journal of Immunology, vol.194, issue.12, pp.5775-80, 2015.
DOI : 10.4049/jimmunol.1402945

E. Dalmas, N. Venteclef, C. Caer, C. Poitou, I. Cremer et al., T Cell-Derived IL-22 Amplifies IL-1??-Driven Inflammation in Human Adipose Tissue: Relevance to Obesity and Type 2 Diabetes, Diabetes, vol.63, issue.6, pp.1966-77, 2014.
DOI : 10.2337/db13-1511

D. Lieb, J. Brotman, M. Hatcher, M. Aye, B. Cole et al., Adipose Tissue 12/15 Lipoxygenase Pathway in Human Obesity and Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.9, pp.1713-202013, 2014.
DOI : 10.1210/jc.2013-4461

S. Zeissig and R. Blumberg, Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces, Current Opinion in Immunology, vol.25, issue.6, pp.690-696, 2013.
DOI : 10.1016/j.coi.2013.09.012

E. Treiner, L. Duban, S. Bahram, M. Radosavljevic, V. Wanner et al., Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1, Nature, vol.107, issue.6928, pp.164-173, 1433.
DOI : 10.1126/SCIENCE.1069639

W. Brown, L. Penaranda, C. Kashyap, P. Williams, B. Clardy et al., Production of alpha-galactosylceramide by a prominent member of the human gut microbiota, PLoS Biol, vol.11, issue.7, 2013.

D. An, S. Oh, T. Olszak, J. Neves, F. Avci et al., Sphingolipids from a Symbiotic Microbe Regulate Homeostasis of Host Intestinal Natural Killer T Cells, Cell, vol.156, issue.1-2, pp.123-156, 2014.
DOI : 10.1016/j.cell.2013.11.042

H. Mcwilliam, R. Birkinshaw, J. Villadangos, J. Mccluskey, and J. Rossjohn, MR1 presentation of vitamin B-based metabolite ligands, Current Opinion in Immunology, vol.34, pp.28-34, 2015.
DOI : 10.1016/j.coi.2014.12.004

A. Corbett, S. Eckle, R. Birkinshaw, L. Liu, O. Patel et al., T-cell activation by transitory neo-antigens derived from distinct microbial pathways, Nature, vol.60, issue.7500, pp.361-366, 2014.
DOI : 10.1038/nature13160

J. Peng, S. Narasimhan, J. Marchesi, A. Benson, F. Wong et al., Long term effect of gut microbiota transfer on diabetes development, Journal of Autoimmunity, vol.53, pp.85-94, 2014.
DOI : 10.1016/j.jaut.2014.03.005

J. Markle, D. Frank, S. Mortin-toth, C. Robertson, L. Feazel et al., Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity, Science, vol.339, issue.6123, pp.1084-1092, 2013.
DOI : 10.1126/science.1233521

J. Dunne, E. Triplett, D. Gevers, R. Xavier, R. Insel et al., The intestinal microbiome in type 1 diabetes, Clinical & Experimental Immunology, vol.109, issue.Suppl. 2, pp.30-37, 2014.
DOI : 10.1111/cei.12321

M. Mclean, D. Dieguez, . Jr, L. Miller, and H. Young, Does the microbiota play a role in the pathogenesis of autoimmune diseases?, Gut, vol.5, issue.(Suppl), pp.332-373, 2015.
DOI : 10.1136/gutjnl-2014-308514

A. Kostic, D. Gevers, H. Siljander, T. Vatanen, T. Hyotylainen et al., The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes, Cell Host & Microbe, vol.17, issue.2, pp.260-73, 2015.
DOI : 10.1016/j.chom.2015.01.001

H. Tilg and A. Moschen, Microbiota and diabetes: an evolving relationship, Gut, vol.504, issue.(Suppl 3), pp.1513-1534, 2014.
DOI : 10.1136/gutjnl-2014-306928

R. Burcelin, M. Serino, C. Chabo, L. Garidou, C. Pomie et al., Metagenome and metabolism: the tissue microbiota hypothesis, Diabetes, Obesity and Metabolism, vol.17, issue.Suppl 1, pp.61-70, 2013.
DOI : 10.1111/dom.12157

URL : https://hal.archives-ouvertes.fr/inserm-00995650

J. Qin, Y. Li, Z. Cai, S. Li, J. Zhu et al., A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, vol.334, issue.7418, pp.55-6010, 1038.
DOI : 10.1038/nature11450

URL : https://hal.archives-ouvertes.fr/hal-01204262

F. Karlsson, V. Tremaroli, I. Nookaew, G. Bergstrom, C. Behre et al., Gut metagenome in European women with normal, impaired and diabetic glucose control, Nature, vol.35, issue.7452, pp.99-103, 2013.
DOI : 10.1038/nature12198

T. Fleming, J. Cuny, G. Nawroth, Z. Djuric, P. Humpert et al., Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?, Diabetologia, vol.1637, issue.4, pp.1151-1156, 2012.
DOI : 10.1007/s00125-012-2452-1

E. Nieuwenhuis, T. Matsumoto, D. Lindenbergh, R. Willemsen, A. Kaser et al., Cd1d-dependent regulation of bacterial colonization in the intestine of mice, Journal of Clinical Investigation, vol.119, issue.5, pp.1241-50, 2009.
DOI : 10.1172/JCI36509DS1

Y. Cho, S. Kee, T. Kim, H. Jin, M. Kim et al., Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus, The Journal of Immunology, vol.193, issue.8, pp.3891-901, 2014.
DOI : 10.4049/jimmunol.1302701